Unbound MEDLINE

Gelsolin concentration in cerebrospinal fluid from patients with multiple sclerosis and other neurological disorders. European journal of neurology : the official journal of the European Federation of Neurological Societies [Eur J Neurol] Journal article

 
TitleGelsolin concentration in cerebrospinal fluid from patients with multiple sclerosis and other neurological disorders.
Author(s)Kulakowska A, Drozdowski W, Sadzynski A, Bucki R, Janmey PA 
InstitutionDepartment of Neurology, Medical University of Bialystok, Bialystok, Poland.
SourceEur J Neurol 2008 Jun; 15(6):584-8.
AbstractBACKGROUND: Gelsolin is a highly conserved intracellular actin-binding protein with an extracellular isoform, plasma gelsolin, for which there is not yet a clearly defined function.
MATERIALS AND METHODS: In this study, we determined gelsolin concentrations in blood and cerebrospinal fluid (CSF) obtained from 25 subjects using immunoblotting and a functional assay that quantifies gelsolin's ability to accelerate actin polymerization.
RESULTS: The gelsolin concentration in CSF, determined by quantitative immunoblotting was 1.2-15.9 microg/ml (average 5.9 +/- 3.8 mug/ml). In samples obtained from patients diagnosed with conditions that do not alter standard CSF clinical tests [(idiopathic cephalgia, ischialgia due to discopathy, and idiopathic (Bell's) facial nerve palsy or entrapment radial neuropathy)], the average gelsolin concentration was 7.2 +/- 4.3 microg/ml. In contrast, the gelsolin concentration in samples obtained from patients diagnosed with multiple sclerosis was 2.1 +/- 0.7 microg/ml, and a similar low concentration was found in a patient recovering from a subarachnoid hemorrhage. The range of CSF gelsolin concentrations determined by the actin polymerization assay was 0.61-9.97 microg/ml (average 3.6 +/- 2.2 microg/ml). These lower values compared with those obtained from immunoblotting analysis suggest that CSF gelsolin may bind other CSF molecules leading to a reduction of its actin-binding activity.
CONCLUSIONS: The results presented here show that CSF gelsolin concentration is significantly altered in certain neurological conditions, including multiple sclerosis, indicating the possible utility of CSF gelsolin levels for diagnostic purposes.
Languageeng
Pub Type(s)Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
PubMed ID18474076
  
Advertise on this site.